Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma

被引：0
|
作者：
Le Ngoc Ha
Amir Iravani
Nguyen Thi Nhung
Ngo Thi Minh Hanh
Febby Hutomo
Mai Hong Son
机构：
[1] 108 Central Military Hospital,Department of Nuclear Medicine
[2] Washington University School of Medicine,Department of Pathology
[3] Mallinckrodt Institute of Radiology,Nuclear Medicine Department
[4] 108 Central Military Hospital,undefined
[5] MRCCC Siloam Hospital,undefined
来源：
Cancer Imaging | / 21卷
关键词：
F-fluorodeoxyglucose; BRAF ; mutation; Histopathologic type; Radioiodine-refractory; Differentiated thyroid carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
    Ma, Chao
    Kuang, Anren
    Xie, Jiawei
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [32] Octreotide scintigraphy in patients with differentiated thyroid carcinoma: Contribution for patients with negative radioiodine scan
    Baudin, E
    Schlumberger, M
    Lumbroso, J
    Travagli, JP
    Caillou, B
    Parmentier, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (07): : 2541 - 2544
  • [33] Prognostic value of FDG PET/CT in radioiodine negative lung metastases from differentiated thyroid cancer
    Nakada, Kunihiro
    Hattori, Naoya
    Sugie, Hiroki
    Masayuki, Sakurai
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [34] Is small dose radioiodine scintigraphy reliable in detecting metastatic tumors from differentiated thyroid carcinoma?
    Nakada, K
    Morita, K
    Shiga, T
    Kaji, T
    Kanegae, K
    Tsukamoto, E
    Tamaki, N
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 261P - 262P
  • [35] Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Patients with Metastatic Differentiated Thyroid Carcinoma
    Zagar, Ivana
    Schwarzbartl-Pevec, Andreja A.
    Vidergar-Kralj, Barbara
    Horvat, Rika
    Besic, Nikola
    [J]. JOURNAL OF THYROID RESEARCH, 2012, 2012
  • [36] Can histopathological factors predict the outcome of radioiodine treatment in patients with differentiated thyroid carcinoma?
    Gao, Zairong
    Chang, Wei
    Zhang, Yongxue
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [37] FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma
    Zettinig, G
    Leitha, T
    Niederle, B
    Kaserer, K
    Becherer, A
    Kletter, K
    Dudczak, R
    [J]. CLINICAL NUCLEAR MEDICINE, 2001, 26 (07) : 599 - 601
  • [38] Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
    Schubert, L.
    Mbekwe-Yepnang, A. M.
    Wassermann, J.
    Braik-Djellas, Y.
    Jaffrelot, L.
    Pani, F.
    Deniziaut, G.
    Lussey-Lepoutre, C.
    Chereau, N.
    Leenhardt, L.
    Bernier, M-O.
    Buffet, C.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (06) : 1573 - 1581
  • [39] Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma
    Nakanishi, Kenichi
    Kikumori, Toyone
    Miyajima, Noriyuki
    Takano, Yuko
    Noda, Sumiyo
    Takeuchi, Dai
    Iwano, Shingo
    Kodera, Yasuhiro
    [J]. CLINICAL NUCLEAR MEDICINE, 2018, 43 (07) : 482 - 485
  • [40] FDG-PET can localize metastatic sites of differentiated thyroid carcinoma in I-131 scan negative patients
    So, Y
    Chung, JK
    Lee, DS
    Lee, MC
    Cho, BY
    Koh, CS
    Lee, JS
    Choi, CW
    Lim, SM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 257P - 258P
12345